Full text
PDF
. 1949 May;28(3):474–481. doi: 10.1172/JCI102093
III. THE FATE OF CITRATE IN ERYTHROBLASTOTIC INFANTS TREATED WITH EXCHANGE TRANSFUSION 1,2
Irving B Wexler
1,2, Joseph B Pincus
1,2, Samuel Natelson
1,2, Julius K Lugovoy
1,2
Irving B Wexler
1Department of Pediatrics, The Jewish Hospital of Brooklyn, Brooklyn, New York
2Department of Biochemistry, The Jewish Hospital of Brooklyn, Brooklyn, New York
Find articles by Irving B Wexler
Joseph B Pincus
1Department of Pediatrics, The Jewish Hospital of Brooklyn, Brooklyn, New York
2Department of Biochemistry, The Jewish Hospital of Brooklyn, Brooklyn, New York
Find articles by Joseph B Pincus
Samuel Natelson
1Department of Pediatrics, The Jewish Hospital of Brooklyn, Brooklyn, New York
2Department of Biochemistry, The Jewish Hospital of Brooklyn, Brooklyn, New York
Find articles by Samuel Natelson
Julius K Lugovoy
1Department of Pediatrics, The Jewish Hospital of Brooklyn, Brooklyn, New York
2Department of Biochemistry, The Jewish Hospital of Brooklyn, Brooklyn, New York
Find articles by Julius K Lugovoy
1Department of Pediatrics, The Jewish Hospital of Brooklyn, Brooklyn, New York
2Department of Biochemistry, The Jewish Hospital of Brooklyn, Brooklyn, New York
1
The third in a series on the mechanism controlling citric acid levels in the blood. The first two papers in this series appeared in the Journal of Clinical Investigation, Vol. 27, pages 446 and 450, 1948.
2
This paper was presented at the Washington meeting of the American Chemical Society, August 30, 1948.
PMCID: PMC439624 PMID: 16695700